Grand River Aseptic Manufacturing Raises Funds for Expansion
Funding boosts life-sciences manufacturing in West Michigan.
Grand River Aseptic Manufacturing (GRAM), a CMO for aseptic pharmaceutical filling, received $9.8 million in capital to expand its facilities, which will create life science jobs in West Michigan. Municipal Employees’ Retirement System (MERS) of Michigan, a nonprofit organization, led the $9.8 million investment round, supported by other Michigan and Indiana-based investors.
“We are delighted with the strong investor response, especially by MERS,” said Tom Ross, GRAM president. “Their considerable support, in combination with the backing from many private investors in our community, is a strong indicator that we’re headed in the right direction. This funding enables us to expand our capabilities, improve our facility, and advance our customer reach, all while creating more highly technical, high-paying jobs in West Michigan.”
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
